KPMG Ireland today announced the eight shortlisted companies that will go forward and compete in the Ireland final of the KPMG Global Tech Innovator competition 2022. The competition, now in its second year in Ireland, provides a platform to showcase the best of Ireland’s emerging tech innovators across a range of sectors.

The finalists were selected from over 40 exceptional entries and will pitch their innovations and growth ambitions to an esteemed panel of judges including Anne Sheehan, general manager of Microsoft; Tommy Kelly, founder and CEO of eShopWorld (ESW); Elaine Coughlan, co-founder and managing partner of Atlantic Bridge; Chris McClelland, founding partner at Broadstone; and Seamus Hand, Managing Partner at KPMG Ireland. The Ireland final will be broadcast online at 4pm on Thursday, 2nd June. Registration is open to the public at www.kpmg.ie/GTI.  

The finalists

The shortlisted companies, which are from Dublin, Limerick, Belfast, Galway and Kildare, offer solutions in areas including fintech, medtech, agtech, real estate and motoring using technologies in blockchain, IoT, AI and machine learning.

The overall winner in Ireland will progress to the final, which will be held during Web Summit 2022 in Lisbon in November, where they will compete with 22 other countries and jurisdictions for the title of KPMG Global Tech Innovator.

The companies that have qualified for the Ireland final are: 

Conor McGinn of Akara

Conor McGinn of Akara

Akara

A facilities management robotics company that develops data-driven automation to increase capacity in hospitals and other healthcare settings through improved efficiency. Akara’s mission is to develop tools that empower front line workers and modernise public health.

Shadi Razak of Angoka

Shadi Razak of Angoka

ANGOKA

An IoT security company focused on protecting machine-to-machine communications for smart cities and mobility. Headquartered in Belfast, with offices in London and The Hague, ANGOKA offers solutions that protect devices’ identities and safeguard critical communications integrity and data provenance, creating trusted connections, even over untrusted networks.

Peter Doyle of Biosimulytics

Peter Doyle of Biosimulytics

BioSimulytics

Developers of a patented breakthrough technology for molecular simulation in early-stage drug discovery and development. Their platform’s technology uses a combination of AI, machine learning, quantum simulation and cloud computing which enable biopharma companies to get new drug molecules to market much faster and with multi-million-dollar savings in R&D costs.

Jennifer Corley of Equitrace

Jennifer Corley of Equitrace

EquiTrace

A dynamic new software solution that traces horses, horse health, medication and welfare. By unleashing the power of the microchip, EquiTrace allows the creation of live accurate databases urgently needed by the equine industry. 

Mark Little and Áine Kerr of Kinzen

Mark Little and Áine Kerr of Kinzen

Kinzen

A solution that empowers the people who keep online communities safe from harmful content, using both human experience and machine learning. Kinzen helps safety professionals, content moderators and public policy makers get ahead of threats such as dangerous misinformation, organised disinformation and hateful content in multiple languages. 

Barry Lunn of Provizio

Barry Lunn of Provizio

Provizio

Developers of a software-defined active safety platform that perceives, predicts, and prevents automotive accidents in real-time using proprietary long range imaging sensors & AI on-the-edge. Provizio’s vision is a future world with zero road deaths. 

Robert Hoban of Offr

Robert Hoban of Offr

Offr

A solution that provides a secure and transparent way for people to make offers to buy or rent real estate. Used by property agents in multiple countries, all buyers are financially qualified, and their offers are verified and published transparently in real time. With its digital contract and deposit process, Offr delivers the world's fastest and most trusted way of transacting real estate.

Stephen Wann of Zoan Biomed

Stephen Wann of Zoan Biomed

Zoan Biomed

Developers of safe, naturally derived, osteogenic medical devices for cutting edge solutions in orthopedics. Zoan’s goal is to improve patients' lifestyles and wellbeing while delivering from a uniquely sustainable business model.

Media queries

If you’re a media professional and have any questions about this article or would like to speak to one of our experts for background or interview purposes, please don't hesitate to reach out to us. Contact Evan O'Quigley of our Communications team for more information.